GetTopicDetailResponse(id=581e26889ea, topicName=依庫珠單抗, introduction=依庫珠單抗, content=null, image=null, comments=0, allHits=1388, url=https://h5.medsci.cn/topic?id=26889, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=20047, tagList=[TagDto(tagId=20047, tagName=依庫珠單抗)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2248257, encodeId=bb39224825ec5, content=<a href='/topic/show?id=581e26889ea' target=_blank style='color:#2F92EE;'>#依庫珠單抗#</a> <a href='/topic/show?id=b5ee116e48b3' target=_blank style='color:#2F92EE;'>#非典型溶血尿毒綜合征#</a>, objectTitle=臉色蒼白、全身乏力，以為是貧血，沒想到竟是致命罕見?。? objectType=article, longId=859669, objectId=e86b8596693e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240508/1715158312120_92910.png, objectUrl=/article/show_article.do?id=e86b8596693e, replyNumber=0, likeNumber=35, createdTime=2025-01-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=e86b8596693e, moduleTitle=臉色蒼白、全身乏力，以為是貧血，沒想到竟是致命罕見??！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e86b8596693e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228985, encodeId=1e4a2228985fa, content=<a href='/topic/show?id=581e26889ea' target=_blank style='color:#2F92EE;'>#依庫珠單抗#</a> <a href='/topic/show?id=de5d1288950' target=_blank style='color:#2F92EE;'>#NMOSD#</a>, objectTitle=Neurology：依庫珠單抗在神經(jīng)脊髓炎譜系障礙中的應(yīng)用, objectType=article, longId=845693, objectId=9b7784569329, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301015/1697393510287_4754896.jpeg, objectUrl=/article/show_article.do?id=9b7784569329, replyNumber=0, likeNumber=120, createdTime=2024-10-03, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=9b7784569329, moduleTitle=Neurology：依庫珠單抗在神經(jīng)脊髓炎譜系障礙中的應(yīng)用, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=9b7784569329)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2206732, encodeId=a7e32206e32bf, content=<a href='/topic/show?id=581e26889ea' target=_blank style='color:#2F92EE;'>#依庫珠單抗#</a> <a href='/topic/show?id=a9de9930377' target=_blank style='color:#2F92EE;'>#非典型溶血性尿毒癥綜合征#</a> <a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a> <a href='/topic/show?id=d17e1515814' target=_blank style='color:#2F92EE;'>#ravulizumab#</a>, objectTitle=ERA 2024：從依庫珠單抗轉(zhuǎn)用ravulizumab的非典型溶血性尿毒癥綜合征患者的特征和安全性：真實(shí)世界研究, objectType=article, longId=827655, objectId=506e82e65561, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240526/1716714369948_8624274.png, objectUrl=/article/show_article.do?id=506e82e65561, replyNumber=0, likeNumber=146, createdTime=2024-05-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=506e82e65561, moduleTitle=ERA 2024：從依庫珠單抗轉(zhuǎn)用ravulizumab的非典型溶血性尿毒癥綜合征患者的特征和安全性：真實(shí)世界研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=506e82e65561)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
